Literature DB >> 24783070

Prevalence of Invasive Aspergillosis Among (PTB) Patients in Kanchipuram, India.

Sivasankari S1, Senthamarai S1, Anitha C1, Apurba Sankar Sastry2, Sandhya Bhatt3, Kumudhavathi M S4, Amshavathani S K5.   

Abstract

BACKGROUND: Tuberculosis (TB) remains a major health problem worldwide. (PTB) is commonly associated with secondary aspergilloma. Repeated exposure of Aspergillus spores can aggravate the bronchial pathology and can manifest as asthmatic episodes. AIM AND
OBJECTIVE: Pulmonary invasive aspergillosis is difficult to evaluate. Culture based diagnosis is time consuming. Hence (PCR) was done to evaluate the invasive fungal aspergillosis in (PTB) patients.
MATERIALS AND METHODS: Eighty sputum samples collected from TB patients were processed as per standard protocol. Species level identification was done using PCR.
RESULTS: Among 80 patients, 26 isolates were obtained, only 8 were Aspergillus species. All Aspergillus were taken up for PCR evaluation.
CONCLUSION: Fungal infection should be suspected in all sputum positive patients. PCR is an effective tool to diagnose invasive aspergillosis.

Entities:  

Keywords:  Aspergillus; Polymerase chain reaction; PulmonaryTuberculosis

Year:  2014        PMID: 24783070      PMCID: PMC4003648          DOI: 10.7860/JCDR/2014/7957.4094

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

Review 1.  Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

Authors:  Themistoklis K Kourkoumpetis; Beth Burgwyn Fuchs; Jeffrey J Coleman; Athanasios Desalermos; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2012-02-23       Impact factor: 9.079

Review 2.  Advances and challenges in management of invasive mycoses.

Authors:  Thomas F Patterson
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

3.  Aspergillus PCR: one step closer to standardization.

Authors:  P Lewis White; Stéphane Bretagne; Lena Klingspor; Willem J G Melchers; Elaine McCulloch; Bettina Schulz; Niklas Finnstrom; Carlo Mengoli; Rosemary A Barnes; J Peter Donnelly; Juergen Loeffler
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

4.  False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics.

Authors:  Viboon Boonsarngsuk; Anuchit Niyompattama; Chalermporn Teosirimongkol; Kanchana Sriwanichrak
Journal:  Scand J Infect Dis       Date:  2010-07

5.  Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.

Authors:  F Reichenberger; J Habicht; P Matt; R Frei; M Solèr; C T Bolliger; P Dalquen; A Gratwohl; M Tamm
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

6.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Authors:  Drosos E Karageorgopoulos; Evridiki K Vouloumanou; Fotinie Ntziora; Argyris Michalopoulos; Petros I Rafailidis; Matthew E Falagas
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

7.  Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.

Authors:  Guizhen Luo; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Authors:  Thomas J Walsh; Shmuel Shoham; Ruta Petraitiene; Tin Sein; Robert Schaufele; Amy Kelaher; Heidi Murray; Christine Mya-San; John Bacher; Vidmantas Petraitis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.

Authors:  Hae-Seong Nam; Kyeongman Jeon; Sang-Won Um; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Won-Jung Koh
Journal:  Int J Infect Dis       Date:  2009-11-11       Impact factor: 3.623

10.  Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay.

Authors:  L Joseph Wheat; Emily Hackett; Michelle Durkin; Patricia Connolly; Ruta Petraitiene; Thomas J Walsh; Kenneth Knox; Chadi Hage
Journal:  Clin Vaccine Immunol       Date:  2007-03-07
View more
  3 in total

1.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

2.  Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host.

Authors:  Ashraf Oe Ahmed; Gawahir A Ali; Wael Goravey
Journal:  Eur J Case Rep Intern Med       Date:  2022-03-21

3.  Prevalence of invasive aspergillosis in suspected pulmonary tuberculosis at a referral tuberculosis hospital in Shandong, China.

Authors:  Jun-Li Wang; Xiao-Lin Zhou; Chao Han; Mao-Shui Wang; Hua Hu
Journal:  Epidemiol Infect       Date:  2020-11-05       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.